---
title: "\"Performance\" Parkson Group turned a loss into a profit in the third quarter, earning 914,000 RMB"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/266697374.md"
description: "PARKSON GROUP announced its third-quarter results for the period ending September this year, with operating revenue of 824 million RMB, a year-on-year decrease of 1.4%. It turned a loss into a profit of 914,000 RMB, compared to a loss of 10.628 million RMB in the same period last year. In the first three quarters of this year, operating revenue was 2.787 billion RMB, a year-on-year increase of 0.2%. It turned a loss into a profit of 23.382 million RMB, compared to a loss of 29.269 million RMB in the same period last year"
datetime: "2025-11-20T09:11:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266697374.md)
  - [en](https://longbridge.com/en/news/266697374.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266697374.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/266697374.md) | [繁體中文](https://longbridge.com/zh-HK/news/266697374.md)


# "Performance" Parkson Group turned a loss into a profit in the third quarter, earning 914,000 RMB

PARKSON GROUP (03368.HK) announced its third-quarter results for the period ending September this year, with operating revenue of RMB 824 million, a year-on-year decrease of 1.4%. It turned a loss into a profit of RMB 914,000, compared to a loss of RMB 10.628 million in the same period last year.

In the first three quarters of this year, operating revenue was RMB 2.787 billion, a year-on-year increase of 0.2%. It turned a loss into a profit of RMB 23.382 million, compared to a loss of RMB 29.269 million in the same period last year

### 相关股票

- [PARKSON GROUP (03368.HK)](https://longbridge.com/zh-CN/quote/03368.HK.md)

## 相关资讯与研究

- [Parkson Retail Group Dissolves Dormant Singapore Subsidiary](https://longbridge.com/zh-CN/news/275098083.md)
- [Jefferies Adjusts XD's Price Target to HK$83.80 From HK$91, Keeps at Buy](https://longbridge.com/zh-CN/news/280983870.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-CN/news/281325910.md)
- [Osl Group FY adjusted non-IFRS income HK$534.1 million](https://longbridge.com/zh-CN/news/281223382.md)
- [13:32 ETApploi Ranks No. 91 on Inc. Magazine's List of the Northeast Region's Fastest-Growing Private Companies in America](https://longbridge.com/zh-CN/news/281224890.md)